The Mstn pathway in CKD may also be activated by oxidative stress, inflammatory cytokines, and uremic toxins [76,77] that may act as inducers of Mstn and are involved in regulating phenotype modifications of VSMCs, closely linked to the occurrence of uremic vasculopathy [78]. This evidence concerns the gene MSTN and chronic kidney disease.